Peoples Bank KS Cuts Stock Holdings in CME Group Inc. $CME

18 Dec 2025, 08:16 by Scott Moore · The Cerbat Gem

Peoples Bank KS cut its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 46.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,134 shares of the financial services provider’s stock after selling 1,885 shares during the quarter. Peoples Bank KS’s holdings in CME Group were worth $577,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Czech National Bank grew its holdings in CME Group by 3.9% in the 3rd quarter. Czech National Bank now owns 91,529 shares of the financial services provider’s stock worth $24,730,000 after acquiring an additional 3,446 shares during the last quarter. Chesley Taft & Associates LLC boosted its holdings in shares of CME Group by 2.7% during the third quarter. Chesley Taft & Associates LLC now owns 1,688 shares of the financial services provider’s stock worth $456,000 after purchasing an additional 45 shares during the period. GFG Capital LLC grew its stake in shares of CME Group by 14.9% in the third quarter. GFG Capital LLC now owns 8,458 shares of the financial services provider’s stock worth $2,285,000 after purchasing an additional 1,095 shares during the last quarter. ST Germain D J Co. Inc. grew its stake in shares of CME Group by 0.4% in the third quarter. ST Germain D J Co. Inc. now owns 26,548 shares of the financial services provider’s stock worth $7,173,000 after purchasing an additional 94 shares during the last quarter. Finally, Assenagon Asset Management S.A. increased its holdings in CME Group by 235.4% during the 3rd quarter. Assenagon Asset Management S.A. now owns 613,883 shares of the financial services provider’s stock valued at $165,865,000 after purchasing an additional 430,851 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on CME. Argus reduced their target price on CME Group from $308.00 to $295.00 in a research note on Friday, October 31st. Bank of America boosted their price objective on shares of CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of CME Group from $310.00 to $318.00 and gave the company a “buy” rating in a research note on Wednesday. Citigroup upgraded shares of CME Group from a “neutral” rating to a “buy” rating and boosted their price target for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. Finally, Royal Bank Of Canada raised their price objective on shares of CME Group from $282.00 to $295.00 and gave the stock a “sector perform” rating in a report on Friday, December 5th. Eight analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, CME Group presently has an average rating of “Hold” and a consensus target price of $290.47.

Get Our Latest Analysis on CME Group

Insider Buying and Selling at CME Group

In other CME Group news, Director Harold Eugene Jr. Ford sold 1,000 shares of the firm’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $263.53, for a total transaction of $263,530.00. Following the completion of the sale, the director directly owned 1,091 shares in the company, valued at approximately $287,511.23. This trade represents a 47.82% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Terrence A. Duffy sold 25,000 shares of the stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the sale, the chief executive officer owned 65,804 shares in the company, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their position. The SEC filing for this sale provides additional information. 0.30% of the stock is owned by company insiders.

CME Group Trading Up 0.3%

Shares of NASDAQ CME opened at $273.74 on Thursday. The stock has a market cap of $98.71 billion, a P/E ratio of 26.53, a price-to-earnings-growth ratio of 4.07 and a beta of 0.28. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1 year low of $224.62 and a 1 year high of $290.79. The firm has a 50-day moving average of $272.42 and a 200 day moving average of $272.03.

CME Group (NASDAQ:CME – Get Free Report) last announced its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter last year, the firm earned $2.68 earnings per share. The business’s revenue for the quarter was down 3.0% on a year-over-year basis. As a group, sell-side analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be paid a $1.25 dividend. The ex-dividend date is Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. CME Group’s payout ratio is presently 48.45%.

CME Group Company Profile

(Free Report)